Related by context. All words. (Click for frequent words.) 73 Vivelle Dot TM 67 Vivelle Dot 67 Azactam 66 ZANAFLEX CAPSULES 66 Wellbutrin XL R 66 Zanaflex 66 DOVONEX 65 Oxy ER 65 GLUMETZA 64 Nascobal 64 Wellbutrin XL ® 64 STRIANT 64 PENTASA 64 Lidoderm R 64 Zanaflex tablets 64 Noven Therapeutics 64 Recurring royalties 63 nonsedating antihistamine 63 ONTAK 63 THALOMID 63 Lidoderm ® 63 PGP Acquisition 63 Amaryl R 63 loss NOL carryforward 62 Sanctura 62 XYREM 62 Oxandrin 62 Maxipime 62 Thalomid ® 62 Fanapt ® 62 KADIAN R 62 Vivelle Dot ® 62 OPANA franchise 62 BioMarin Genzyme LLC 62 PLAVIX R 62 PDP MLR 62 4Q FY# 62 ABILIFY R 61 VANTAS 61 PhosLo 61 ESTRASORB 61 continuingoperations 61 Kerastick 61 Pexeva 61 Aloxi injection 61 Altoprev 61 PhosLo R 61 operatingincome 61 adopting SFAS #R 61 Lilly ICOS joint venture 61 Eligard R 61 Ethyol 61 OPANA ER 61 3Q FY# 61 Sensipar 61 Fortamet 60 XOPENEX Inhalation Solution 60 SOLODYN R 60 Megace ES 60 AVINZA 60 CCXA 60 Infergen R 60 noninterest expense decreased 60 Kerastick ® 60 TACLONEX 60 Partnered Brands segment 60 Istalol 60 PANZYTRAT 60 Testim 60 CRINONE 60 CARBATROL 60 ACTONEL 60 Klean Prep TM 60 earnings pershare 60 BioGlue revenues 60 Rapaflo 60 Soriatane 60 SOLODYN 60 Fine Chemicals segment 59 Hectorol R 59 Kyowa Kirin 59 Fortical 59 prioryear 59 ABELCET 59 RAPTIVA R 59 ALTACE 59 Teveten 59 operating income1 59 PRAVACHOL R 59 Orthovisc R 59 ARCALYST ® 59 metoprolol succinate 59 Lidoderm 59 RYZOLT 59 Smecta ® 59 Nuo Hua 59 XLGB 59 Eligard ® 59 Estrostep 59 Voltaren Gel 59 ApothecaryRx 59 Frova ® 59 XIBROM 59 Actimmune R 59 Sirton 59 Zovirax ® 59 ZANAFLEX tablets 59 Non GAAP adjusted EBITDA 59 KADIAN ® 59 Vancocin R 59 NETg acquisition 59 Polymer Additives segment 59 SORL consolidated 59 Sular 59 prescription dermatological 59 netsales 59 Daytrana ™ 59 IV Busulfex 59 Crinone 59 Naprelan R 59 Shire BioChem Inc. 59 Symphony GenIsis 59 ended September# 58 Frova R 58 LIDODERM 58 Ultram ER 58 Oxandrin R 58 MEP Joint Venture 58 ZALBIN ™ 58 tramadol HCl 58 ZYFLO CR 58 BUPHENYL R 58 Replens ® 58 RAPTIVA r 58 Doryx 58 generic oral contraceptives 58 Chemicals Segment 58 Azmacort R 58 specialty injectables 58 Baobaole chewable tablets 58 DSD Dairy segment 58 Programmer Paradise segment 58 unamortized portion 58 #.#/diluted share 58 FROVA 58 Fanapt iloperidone 58 Zanaflex Capsules 58 ZEGERID 58 STRIANT ® 58 Lipofen R 58 Radix Isatidis Dispersible Tablets 58 propoxyphene containing 58 ESTRASORB ® 58 CLARINEX 58 Clindesse R 58 IV APAP 58 Mircette 58 Orapred 58 millioncompared 58 invoiced shipments 58 Agenerase 58 oxycodone hydrochloride extended 58 Olefins Polyolefins 58 thefourth quarter 58 Keflex 58 COLAZAL R 58 fexofenadine hydrochloride 57 Astaris joint venture 57 Individual Annuities segment 57 PMPS brand 57 Enablex 57 CRINONE 8 57 LOPROX R 57 LUMIGAN R 57 PROTONIX 57 ACTIQ 57 ev3 peripheral vascular 57 BeneFIX 57 upholstery fabrics segment 57 Akorn Strides LLC 57 AMRIX 57 EBITD 57 Glumetza 57 Zovirax R 57 Sanctura XR 57 ARCALYST R 57 Domilens 57 BioGlue ® 57 Global Generics 57 Estrasorb 57 DORYX 57 BioGlue R 57 Equity Investees 57 HealthStream Learning 57 Benazepril 57 Ditropan XL 57 Vinyls segment 57 thequarter 57 LIALDA MEZAVANT 57 Elestat 57 Somatuline R Depot 57 OLUX 57 INFeD 57 BD Biosciences segment 57 clopidogrel bisulfate 57 Abelcet 57 LIFO adjustment 57 contractual minimums 57 danoprevir 57 generic clopidogrel bisulfate 57 ASUR regulated 57 Polyurethanes segment 57 Zegerid OTC 57 Nicomide ® 57 Dovonex 57 Endoscopic Technologies 57 Preclinical eValuation 57 Lilly ICOS 57 Combunox 57 Akorn Strides 57 sumatriptan succinate 57 risedronate sodium tablets 57 Thalomid R 57 unabsorbed overhead 57 ALTANA Pharma 57 NA HME 56 Angiomax Angiox 56 MFB Corp 56 ABILIFY ® 56 palonosetron hydrochloride injection 56 FDIC indemnification 56 Nascobal ® 56 levocetirizine 56 Sular formulation 56 Surface Specialties 56 Mircette R 56 ZOCOR 56 ALTANA Chemie 56 ofapproximately 56 Aprovel R 56 Cetrotide R 56 accretable 56 unbilled revenue 56 Paxil CR TM 56 Dorzolamide 56 Atelvia 56 Xenazine ® 56 Pharma Medica 56 EBITDAO 56 OLEPTRO TM 56 Strativa 56 Gonal f 56 valdecoxib 56 SUPPRELIN R LA 56 losartan potassium 56 Cetirizine Hydrochloride Syrup 56 AZASITE 56 TEB adjustment 56 Prenate Elite 56 Alaven 56 SCHWARZ PHARMA 56 OshKosh wholesale 56 Proquin XR 56 unbranded generics 56 Testim ® 56 SangStat 56 USD #.#bln [001] 56 contraceptive Yasmin 56 SUPPRELIN LA 56 Claravis 56 GLASSIA 56 adjusted EBITDAS 56 preneed cemetery 56 Mr. Movens 56 CRINONE R 56 Currency translation effects 56 Interest Expense Interest expense 56 WinRho SDF 56 Nascobal Nasal Spray 56 paroxetine sertraline 56 Sotret 56 Nascobal R 56 Angelini Labopharm 56 Celmed 56 RISPERDAL CONSTA 56 Remodulin 56 RESTASIS 56 Aldurazyme 56 SUSTIVA R 56 Allegra ® 56 increaseof 56 Xolegel 56 Components Segment 56 RISPERDAL 56 Lamictal ODT 56 Taclonex 56 Ferrlecit 56 ZYFLO 56 FUEL CHEM segment 56 FiberChoice 56 adjusted1 56 R hylan GF 56 doxercalciferol 56 #compared 56 Daytrana TM 56 comparedto 56 Yidasheng 56 ECR Pharmaceuticals 56 Bilive 56 FARESTON ® 56 GYN Surgical revenues 56 Ginkor Fort ® 56 INTEGRILIN 56 Stavzor 56 FEMCON FE 56 Amnesteem 56 AGGRASTAT ® 56 #.# perdiluted 56 Fortical R 56 Sumatriptan 56 Oravig 56 1Q FY# 56 Argatroban 56 2Q FY# [001] 56 Newsstand Distribution Services 56 IV Infusion Therapy 56 Refractories segment 56 Durect 56 Valacyclovir 56 ETHEX Corporation 56 Auxilium Pharma 56 LIFO adjustments 55 netincome 55 Androgel R 55 BIOCEUTICALS 55 Anhui Jucheng 55 calcium acetate 55 hydrochloride tablets 55 norethindrone acetate 55 Sensipar R 55 HemoStase 55 Motorhome Resorts Segment 55 loratadine 55 ZEGERID Capsules 55 unfavorable variances 55 Fab 3E 55 MethyPatch 55 oxcarbazepine 55 Nabi HB 55 Astepro 55 Hesperion acquisition 55 tramadol ER 55 Wellbutrin SR 55 ZEGERID OTC 55 RAZADYNE 55 XAGRID 55 Mircette R oral contraceptive 55 FHLB advances decreased 55 ascompared 55 NOL carryforwards 55 Zelapar 55 LUCENTIS r 55 LUVOX CR 55 SILENOR 55 months endedSeptember 55 Regentek 55 LIFO reserve 55 Bupropion HCl ER 55 Esprit Pharma 55 Clinical Diagnostics segment 55 OPANA 55 WhiteWave Morningstar 55 TIMERx 55 Gross Margin Gross 55 Dismed 55 Oncaspar 55 Detrol Detrol LA 55 MOVIPREP R 55 balsalazide 55 Lithobid 55 GEM #S 55 ECU netbacks 55 Monovisc TM 55 Precose 55 Evamist TM 55 research anddevelopment 55 RESTASIS ® 55 generic Adderall XR 55 sevelamer carbonate 55 Detrol LA 55 Minrad 55 Enjuvia 55 SWDCC 55 Megace R ES 55 R tizanidine hydrochloride 55 BioThrax ® 55 Imagewear coalition 55 generic oral contraceptive 55 Organichem 55 AlloDerm R 55 Curosurf 55 Aczone 55 Cytec Surface Specialties 55 MVAS gross 55 Retavase 55 AndroGel R 55 Naglazyme 55 tizanidine 55 AGY Asia 55 granulated mesalamine 55 Zenpep 55 ZANAFLEX tablets shipments 55 Cold Remedy segment 55 ETHEX 55 GLUMETZA ® 55 Filgrastim 55 uncollectible accounts receivable 55 NeedleTech 55 Dronabinol 55 CytoGam 55 Timolol ophthalmic solution 55 Alphagan P 55 nonoperating expense 55 cinacalcet HCl 55 Zila Nutraceuticals 55 quarter# 55 oral hypoglycemic agent 55 Opana R 55 accumulated undistributed 55 Arixtra ® 55 Amrix 55 Ribavirin royalties 55 DAC unlocking 55 MedSurg Equipment 55 ACEON R 55 Mestinon 55 Hulunbeier Beixue 55 EvaMist 55 andoperating 55 Vacation Interval sales 55 Ps.7 55 Proleukin 55 Testim R 55 Omeprazole 55 TPIAO 55 Teveten HCT 55 TRISENOX 55 Tritace R 55 amlodipine benazepril 55 Sepra 55 amifostine 55 c Includes 55 OTTI charges 55 nalbuphine ER 55 norgestimate 55 Tecstar Automotive Group 55 UVIDEM 55 Naglazyme galsulfase 55 Brooks Eckerd acquisition 55 ONEOK Partners segment 55 pravastatin Pravachol 54 JunJing III 54 Actonel ® 54 CIMA LABS 54 Seroquel quetiapine 54 Optivar 54 CRIXIVAN 54 GYN Surgical 54 Eloxatin ® 54 GRALISE 54 Somatuline Depot 54 Timeshare segment 54 Cardene R 54 generic omeprazole 54 COLAZAL 54 ReFacto 54 platelet aggregation inhibitor 54 d Represents 54 Therics 54 5 lipoxygenase inhibitor 54 Quinapril 54 LIFO inventory decrement 54 Naglazyme R 54 3Q FY# representing 54 Biaxin clarithromycin 54 LifeVantage Announces 54 Ultane Sevorane 54 Downstream CCS 54 VISICOL R 54 quinapril 54 Preneed funeral sales 54 Radix Isatidis dispersible tablets 54 unconsolidated joint 54 Arthur Bedrosian president 54 Prandin 54 Chlor Alkali segment 54 DiaMed acquisition 54 Pennsaid ® 54 MNOK #.# 54 DELATESTRYL 54 Visa indemnification 54 morphine sulfate extended 54 Zorbtive TM 54 Evaporative Cooling segment 54 Noninterest Expense Noninterest expense 54 ZEFFIX 54 generic Valtrex 54 Striant 54 Pro forma Adjusted EBITDA 54 OMNARIS Nasal Spray 54 Nabumetone 54 markets HP Acthar 54 sublingual tablets 54 BLU U R 54 recognized ratably 54 Willi Food commented 54 Rx Pharmaceuticals 54 Medicare Advantage MLR 54 AstraZeneca Toprol XL 54 stock basedcompensation 54 Corus Aluminum 54 Mylan Bertek 54 emtricitabine tenofovir 54 OraTest R 54 Currency translation negatively impacted 54 #.#bn rub [004] 54 Medication Delivery 54 Normalized EBITDA 54 Targretin capsules 54 AmBisome 54 InvaGen 54 Halotron revenues 54 AMPAC ISP Holdings 54 invoiced shipment 54 EpiPen Auto Injector 54 Perforomist 54 Xalatan 54 FACTIVE tablets 54 QLT USA 54 PLAVIX ® 54 Wireline adjusted EBITDA 54 EBITDA1 54 Wholesale Leathercraft 54 thethird quarter 54 Vitaflo Scandinavia AB 54 Nasacort 54 RAPTIVA 54 Danazol 54 Levoxyl R 54 ULTRASE 54 CDP# 54 postretirement benefit 54 noninterest expense totaled 54 inventories revalued 54 Benicar HCT 54 VANTAS R 54 thrombopoietin TPO 54 JDS Pharmaceuticals 54 NeoVisc 54 Consolidated EBITDA Margin 54 reagent disc 54 Combivent 54 Xibrom TM 54 rabeprazole 54 Flector pain patch 54 Androgel 54 nonpharmacy 54 Federal Mogul Alapont 54 Cellegy 54 Lubrizol Additives segment 54 Fortigel 54 Fanapt TM 54 MA PFFS 54 1Q FY# representing 54 offiscal 54 NutropinAq ® 54 RYZOLT TM 54 amlodipine maleate 54 promissory note receivable 54 Licorice Products segment 54 noninterest expense partially offset 54 Macoven 54 Clindesse TM 54 Corrugated Packaging segment 54 Nitrolingual 54 Lasertel subsidiary 54 Illumigen Biosciences Inc. 54 Lipofen 54 anincrease 54 fiscal# 54 shippable backlog 54 Symphony Icon 54 Katonah Debt Advisors 54 Phosphates segment 54 AndroGel ® 54 Orapred ODT 54 interferon gamma 1b 54 MSR hedging 54 Sinobiopharma 54 adjusted EBITDAR 54 Rader Farms 54 DSD Dairy 54 Explosive Metalworking segment 54 #F YTD 54 Oxyglobin 54 Xeloda ® 54 Compensation Expenses 54 Eligard 54 pro forma adjusted EBITDA 54 INFeD R 54 theprior 54 #.Net 54 Visiting Nurse VN 54 OSMOPREP 54 Ceftin 54 Forlax R 54 Soriatane R 54 DJOFL 54 FazaClo 54 OLEPTRO ™ 53 dorzolamide 53 Flutiform TM 53 SunOpta Foods 53 Biaxin XL 53 segments Orthopaedic Implants 53 APTIMA HPV assay 53 Curacyte 53 Cipralex ® 53 Tofranil 53 Symphony ViDA 53 PENNSAID 53 Copano commodity 53 Contingent Consideration 53 Avinza 53 Pro forma EPS 53 cefdinir 53 Colazal 53 ENTOCORT EC 53 Eltek commented 53 NutropinAq R 53 #mg dosage strength 53 Glucotrol XL 53 ZYFLO R 53 AVONEX ® 53 Oxytrol R 53 Q1 #F 53 Lexiscan R 53 CalFirst Bancorp 53 Fenoglide 53 ONSOLIS 53 FFO payout ratio 53 R rilonacept Injection 53 Ps.2 53 FineTech 53 ZANAFLEX 53 include ClindaReach TM 53 Prepaid churn 53 EUR -#.# -#.# [001] 53 PTOI 53 Depreciation Amortization Taxes 53 Sustiva efavirenz 53 prescription prenatal vitamins 53 Preotact 53 b Relates 53 Lexiscan ® 53 LIFO provision 53 efficiency ratio teb 53 Cold Remedy 53 Triglide 53 Vyvx advertising 53 PULMICORT 53 Exalgo 53 USOGP 53 Cytogen marketed 53 Noninterest expense totaled 53 c Represents 53 acquired Brooks Eckerd 53 Custom folding carton 53 Roadway Sensors 53 Enventis Sector 53 MOVIPREP 53 bakery cafe sales 53 Adjusted EBITDA1 53 noncash goodwill 53 Retail Leathercraft 53 quarterended 53 c Relates 53 Azithromycin Dispersible Tablets 53 BioTie 53 Effexor venlafaxine 53 venlafaxine hydrochloride 53 Drivetrain segment 53 Mg Uk 53 currency remeasurement 53 Positively impacting 53 Cenestin 53 reduce serum phosphate 53 bupropion hydrochloride extended 53 Suprax 53 Extra Ordinary Items 53 excluding BIBP 53 Lung Rx 53 Adjusted Gross Profit 53 Oracea 53 CECT branded handsets 53 ended December# 53 normalized EBIT 53 Satisloh 53 Cytogen 53 Q1 FY'# 53 #.#bn rub [005] 53 Ps.6 53 AVINZA ® 53 YTD Fiscal 53 HCl Tablets 53 Cozaar Hyzaar 53 Accounts receivables 53 Focalin XR 53 XOPENEX HFA 53 AGGRASTAT R 53 Scantron segment decreased 53 SmartGrowth Deposits 53 Nicomide R 53 loan chargeoffs 53 Pfizer Camptosar 53 Cedax 53 dacetuzumab collaboration 53 Forlax ® 53 Healive TM 53 Lysteda 53 Femring ® 53 Near Infrared Optics 53 ` #cr [002] 53 unrealized derivative 53 totaled USD#.#m 53 ImmunoCyt TM uCyt + 53 THALOMID R 53 Atria Genetics 53 EnPro consolidated 53 Armkel 53 FINANCIAL DETAILS 53 Q3 FY'# 53 JUVISTA 53 Zeneus 53 Paladin Labs 53 trospium 53 Onco TCS 53 Composite Fibers 53 #mg capsules [001] 53 Ps.3 53 thousand BOEPD 53 NeoResins 53 Milestone Payments 53 oxycodone CR 53 Gestiva TM 53 apaziquone 53 OTTI write downs 53 ularitide 53 Dexilant 53 DPAC amortization 53 ENTEREG 53 IXEMPRA 53 Methylphenidate Transdermal System 53 Engineered Materials segment 53 Felodipine 53 GBP #.#m [003] 53 glucokinase activator 53 Depakene 53 incentive accruals 53 PerClot 53 Rs.#.#cr 53 Zyflo CR 53 Adalat CC 53 Naprelan 53 Besylate 53 kiwifruit puree 53 FACTIVE R gemifloxacin 53 Thorough QT 53 Cardiac Surgery Systems 53 RMB2 #.# 53 EFT Processing Segment 53 Lovaza TM 53 Beixue Group 53 normalized FFO 53 sunitinib sorafenib 53 Zila Biotechnology 53 DAC unlock 53 Fortovase 53 Zentaris 53 CAELYX 53 Belinostat 53 EUR#.#million 53 Angio Seal TM 52 AmericanSingles segment 52 Gralise 52 Octane Additives 52 Fabricated Products segment 52 Drug eluting stent 52 Oxandrin ® 52 RMB#.#million 52 Pro forma adjusted EBITDA 52 Didanosine 52 Variable annuity sales 52 Gynazole 1 52 7ACA 52 Surface Specialties acquisition 52 Benicar ® 52 SymlinPen 52 embolics 52 Vasotec 52 Cobalt Gordian 52 Orthovisc ® 52 GSCT program 52 Non GAAP Operating Margin 52 -# -# -#,# 52 SEK #.#M #.# 52 Variable annuity 52 Noninterest expense decreased 52 Synera TM 52 Non CWI 52 - Adjusted [030] 52 NTIC consolidated 52 Adjusted EBITDA excludes 52 Pfizer Norvasc 52 unitholder distributions 52 Adoxa 52 carryforwards 52 Recreational Accessories segments 52 Luvox CR 52 Invicorp R 52 9M FY# [002] 52 cicletanine 52 commercialize ZYFLO CR 52 Stalevo 52 GMDB 52 BPLP 52 generic Prilosec 52 unamortized deferred 52 regarding Heska 52 Branded Pharmaceuticals 52 Fx adj 52 Submits NDA 52 Pliaglis 52 Interpharm 52 Elestrin 52 INKP 52 intangible impairment 52 Gabapentin Tablets 52 reinsurance commutations 52 VALSTAR 52 Noven 52 Midlothian Laboratories 52 Fazenda Brasileiro Mine 52 Munghana Lonene Listenership 52 Viatris 52 Engineered Products segment 52 Prozac fluoxetine 52 Exterran stockholders 52 Supplies Distributors 52 Sumatriptan Succinate 52 torsemide ER 52 Pro forma EBITDA 52 ADDERALL XR 52 AstraZeneca Nexium 52 Luxiq 52 Sanofi Aventis Allegra 52 Acetate Products 52 Q2 #F 52 X Ceptor 52 Peyronie disease Frozen Shoulder 52 Increlex TM 52 Aldara ® 52 ninemonths 52 Cetrotide 52 PictureMe Portrait Studio 52 AMEVIVE 52 unannualized 52 PharMerica LTC 52 DepoDur TM 52 Neurobionix 52 totaled EUR#.#m 52 Wellbutrin XL 52 intersegment revenues 52 ZETIA totaled 52 Astelin 52 EUR #,# Mio 52 trospium chloride 52 Interest expense decreased 52 Reclast zoledronic acid 52 SEASONIQUE R 52 Release Tablets 52 Efudex 52 c Consists 52 Ortho Cept 52 totaled MEUR 52 Polymeropoulos 52 oxandrolone USP 52 EBITDAA 52 Xin Aoxing 52 Smokeless Products 52 Klean Prep ® 52 Disposable Protective Apparel 52 PentaStaph 52 Aegerion 52 Gonal f R 52 #,# ADMTs 52 Preotact ® 52 DeVenture 52 Boniva ibandronate 52 HP Acthar R 52 UCB Keppra 52 Fuel Specialties 52 DRAXIS 52 DuoNeb 52 SigmaTron 52 olmesartan medoxomil hydrochlorothiazide 52 Losartan Potassium 52 Rotarix ® 52 Standardized distributable cash 52 SEASONALE 52 R bisoprolol Euthyrox 52 MARRIOTT REVENUES totaled 52 f Represents 52 OsmoPrep 52 mequinol 52 Lodrane 52 Cardene IV 52 Currency translation 52 Urokinase 52 Opana ® 52 Unitholder distributions 52 Alphagan 52 Ixempra 52 Fluticasone Propionate 52 Kasco segment 52 Unfavourable Changes 52 Custom Electrical Components 52 Huipu 52 Solazed 52 USD#.#m [008] 52 ESP Pharma 52 non recourse RISPERDAL 52 EBITDAF 52 NRx 52 Ethypharm SA 52 lipid lowering medications 52 BOLI COLI 52 Announces Tentative Approval 52 Elevess 52 Specialty Chemicals Segment 52 Scantron segment increased 52 Operating netbacks 52 PV module shipments 52 XLTEK 52 Urocidin TM 52 ProQuin XR 52 Contura MLB 52 Paroxetine 52 Retransmission consent revenue 52 Denville Scientific 52 enoxaparin sodium injection 52 TOCOSOL Paclitaxel 52 Omnicef 52 copromotion 52 #.#mln rub [006] 52 Procardia XL 52 - Adjusted [006] 52 EDITDA 52 Printed Circuit Materials 52 Aloprim 52 ELESTAT 52 Benicar R 52 Filtran Microcircuits Inc. 52 Billable headcount 52 RITUXAN 52 Humibid 52 Aerostructures segment 52 Prescriptions filled 52 warranty accruals 52 Pigments segment 52 Coreg CR 52 Erbitux colon cancer 52 Sycrest 52 soft gelatin capsule 52 polymer intermediates 52 amort 52 nondeductible expenses 52 phytosterol revenues 52 Solodyn 52 ratably 52 Specialty Resins 52 Toprol 52 EBIAT 52 loss carrybacks 52 cash fl ows 52 Custom Sheet 52 syndrome overactive bladder 52 Housewares Segment 52 NEBIDO